CL2011000393A1 - Metodo para preparar una microesfera de liberacion sostenidaque comprende disolver la sustancia activa y un polimero biodegradable en solvente acuoso y no acuoso respectivamente, formar una emulsion entre ambas soluciones, adicionarle un cosolvente y agregarla a un solvente acuoso para formar la microesfera y remover el solvente organico. - Google Patents

Metodo para preparar una microesfera de liberacion sostenidaque comprende disolver la sustancia activa y un polimero biodegradable en solvente acuoso y no acuoso respectivamente, formar una emulsion entre ambas soluciones, adicionarle un cosolvente y agregarla a un solvente acuoso para formar la microesfera y remover el solvente organico.

Info

Publication number
CL2011000393A1
CL2011000393A1 CL2011000393A CL2011000393A CL2011000393A1 CL 2011000393 A1 CL2011000393 A1 CL 2011000393A1 CL 2011000393 A CL2011000393 A CL 2011000393A CL 2011000393 A CL2011000393 A CL 2011000393A CL 2011000393 A1 CL2011000393 A1 CL 2011000393A1
Authority
CL
Chile
Prior art keywords
aqueous
microsphere
solvent
cosolvent
emulsion
Prior art date
Application number
CL2011000393A
Other languages
English (en)
Inventor
Nak Hyun Lim
Sung Geun Kim
Se Yeon Kim
Hyung Joon Jung
Kyung Hoi Cha
Original Assignee
Dong Kook Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41722136&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2011000393(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dong Kook Pharm Co Ltd filed Critical Dong Kook Pharm Co Ltd
Publication of CL2011000393A1 publication Critical patent/CL2011000393A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Método para preparar una microesfera de liberación sostenida que comprende disolver la sustancia activa y un polímero biodegradable en solvente acuoso y no acuoso respectivamente, formar una emulsión entre ambas soluciones, adicionarle un cosolvente y agregarla a un solvente acuoso para formar la microesfera y remover el solvente orgánico.
CL2011000393A 2008-08-29 2011-02-23 Metodo para preparar una microesfera de liberacion sostenidaque comprende disolver la sustancia activa y un polimero biodegradable en solvente acuoso y no acuoso respectivamente, formar una emulsion entre ambas soluciones, adicionarle un cosolvente y agregarla a un solvente acuoso para formar la microesfera y remover el solvente organico. CL2011000393A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020080085368A KR101113044B1 (ko) 2008-08-29 2008-08-29 용매교류증발법에 의한 서방출성 미립구의 제조방법

Publications (1)

Publication Number Publication Date
CL2011000393A1 true CL2011000393A1 (es) 2011-08-19

Family

ID=41722136

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2011000393A CL2011000393A1 (es) 2008-08-29 2011-02-23 Metodo para preparar una microesfera de liberacion sostenidaque comprende disolver la sustancia activa y un polimero biodegradable en solvente acuoso y no acuoso respectivamente, formar una emulsion entre ambas soluciones, adicionarle un cosolvente y agregarla a un solvente acuoso para formar la microesfera y remover el solvente organico.

Country Status (11)

Country Link
US (1) US20110200679A1 (es)
EP (1) EP2327397A2 (es)
JP (1) JP2012501321A (es)
KR (1) KR101113044B1 (es)
CN (1) CN102137657A (es)
BR (1) BRPI0917714A2 (es)
CL (1) CL2011000393A1 (es)
CO (1) CO6341545A2 (es)
MX (1) MX2011002210A (es)
RU (1) RU2011111714A (es)
WO (1) WO2010024615A2 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120011344A (ko) * 2010-07-21 2012-02-08 에스케이케미칼주식회사 고분자 미립구의 제조방법 및 그 방법에 의해 제조된 고분자 미립구
CN102755627B (zh) * 2012-01-31 2014-04-02 赛乐医药科技(上海)有限公司 一种戈舍瑞林缓释植入剂的制备方法
US9636308B2 (en) 2013-03-15 2017-05-02 Oakwood Laboratories LLC High drug load buprenorphine microspheres and method of producing same
US9393211B2 (en) * 2013-03-15 2016-07-19 Oakwood Laboratories LLC High drug load buprenorphine microspheres and method of producing same
RU2694901C2 (ru) * 2013-04-18 2019-07-18 Шаньдун Луе Фармасьютикал Ко., Лтд Фармацевтические композиции микросфер гозерелина с пролонгированным высвобождением
BR112016002342A8 (pt) * 2013-08-06 2018-01-23 Dong Kook Pharm Co Ltd microesfera entecavir, método para preparação de uma microesfera entecavir, e, composição farmacêutica
JP6238401B2 (ja) * 2013-10-28 2017-11-29 日本化薬株式会社 生理活性ペプチド徐放性微粒子及びその製造方法
KR101695440B1 (ko) * 2014-09-12 2017-01-11 주식회사 고려비엔피 불화퀴놀론계 항생제를 담지한 생분해성 고분자 미립구형 서방출 제제의 제조방법
KR101779846B1 (ko) 2015-08-31 2017-10-10 주식회사 티케이케미칼 나노다공성을 갖는 서방성 미분말과 그 제조방법
KR101961848B1 (ko) * 2016-08-25 2019-03-25 영진약품 주식회사 C18:1, c18:1(oh) 또는 c18:2의 장쇄 지방산이 포함된 오일류를 포함한 방출억제제를 적용한 서방출성 마이크로스피어 및 이의 제조방법
MX391306B (es) * 2017-01-31 2025-03-21 Veru Inc COMPOSICIONES PARA LA LIBERACIÓN PROLONGADA DE ANTAGONISTAS DE LA HORMONA LIBERADORA DE GONADOTROPINA (GnRH)
KR102142026B1 (ko) * 2017-05-31 2020-08-06 주식회사 대웅제약 방출제어가 용이한 서방성 약물 미립자의 제조방법
KR102047983B1 (ko) * 2017-11-30 2019-11-22 주식회사 지투지바이오 안전성 및 저장 안정성이 향상된 생분해성 미립구의 제조방법
KR20190121699A (ko) * 2018-04-18 2019-10-28 (주)인벤티지랩 데옥시콜린산을 포함하는 피하 주사용 조성물 및 이의 제조 방법
WO2019203543A1 (ko) * 2018-04-18 2019-10-24 (주)인벤티지랩 데옥시콜린산을 포함하는 피하 주사용 조성물 및 이의 제조 방법
KR102185348B1 (ko) * 2018-12-17 2020-12-01 주식회사 지투지바이오 데슬로렐린을 함유하는 서방형 주사제 및 그 제조방법
KR102212717B1 (ko) * 2019-11-08 2021-02-08 환인제약 주식회사 지속 방출을 위한 마이크로스피어 및 이의 제조 방법
CA3236685A1 (en) * 2021-11-18 2023-05-25 Inventage Lab Inc. Method for preparing microparticles containing poorly soluble drugs
EP4413977A4 (en) * 2021-11-18 2025-11-05 Inventage Lab Inc METHOD FOR PREPARING MICROPARTICLES CONTAINING LOWLY SOLUBLE MEDICINES
CN114668729B (zh) * 2022-02-25 2023-09-29 浙江圣兆药物科技股份有限公司 一种曲普瑞林缓释制剂的连续化生产方法
WO2024049279A2 (ko) * 2022-09-01 2024-03-07 주식회사 지투지바이오 루프롤라이드를 포함하는 서방형 미립구, 이를 포함하는 주사제제 및 이의 제조방법
KR102742892B1 (ko) * 2022-09-01 2024-12-16 주식회사 지투지바이오 류프롤라이드를 포함하는 서방형 미립구, 이를 포함하는 주사제제 및 이의 제조방법
WO2024122991A1 (ko) * 2022-12-05 2024-06-13 (주)인벤티지랩 복합 수상 용액를 이용한 마이크로 입자에 잔류하는 유기 용매의 제거 방법
KR20250072362A (ko) * 2023-11-16 2025-05-23 주식회사 펩트론 초기 방출량이 증가된 서방형 제제 및 이의 제조방법
KR20260002273A (ko) * 2024-06-28 2026-01-06 주식회사 지투지바이오 고생산량을 갖는 미립구의 생산방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366734A (en) 1981-02-16 1994-11-22 Zeneca Limited Continuous release pharmaceutical compositions
TW448055B (en) 1995-09-04 2001-08-01 Takeda Chemical Industries Ltd Method of production of sustained-release preparation
EP0877033B1 (en) * 1997-05-08 2007-09-12 Amarnath Maitra A process for the preparation of highly monodispersed polymeric hydrophilic nanoparticles
KR100754352B1 (ko) * 1999-05-24 2007-08-31 소너스파머슈티칼즈인코포레이티드 난용성 약물용 에멀젼 부형제의 제조방법
JP3523821B2 (ja) * 2000-02-09 2004-04-26 ナノキャリア株式会社 薬物が封入されたポリマーミセルの製造方法および該ポリマーミセル組成物
KR100433061B1 (ko) 2001-09-12 2004-05-28 김시환 휴대용 멀티 표시장치
WO2003055470A1 (en) * 2001-12-26 2003-07-10 Takeda Chemical Industries, Ltd. Novel microsphere and method for production thereof
KR100709015B1 (ko) * 2002-11-13 2007-04-18 (주)아모레퍼시픽 지속적 약물방출이 가능한 고분자 미립구 및 그 제조방법
CA2550518C (en) * 2003-12-19 2010-02-09 Scf Technologies A/S Systems for preparing fine particles and other substances
TW200529890A (en) * 2004-02-10 2005-09-16 Takeda Pharmaceutical Sustained-release preparations
KR100816065B1 (ko) * 2006-11-27 2008-03-24 동국제약 주식회사 초기 방출억제 특성이 우수한 서방출성 마이크로캡슐의제조방법 및 이에 의해 제조되는 마이크로캡슐

Also Published As

Publication number Publication date
MX2011002210A (es) 2011-06-24
US20110200679A1 (en) 2011-08-18
JP2012501321A (ja) 2012-01-19
RU2011111714A (ru) 2012-10-10
KR101113044B1 (ko) 2012-02-27
WO2010024615A3 (ko) 2010-06-17
KR20100026384A (ko) 2010-03-10
EP2327397A2 (en) 2011-06-01
CN102137657A (zh) 2011-07-27
CO6341545A2 (es) 2011-11-21
WO2010024615A2 (ko) 2010-03-04
BRPI0917714A2 (pt) 2016-02-16

Similar Documents

Publication Publication Date Title
CL2011000393A1 (es) Metodo para preparar una microesfera de liberacion sostenidaque comprende disolver la sustancia activa y un polimero biodegradable en solvente acuoso y no acuoso respectivamente, formar una emulsion entre ambas soluciones, adicionarle un cosolvente y agregarla a un solvente acuoso para formar la microesfera y remover el solvente organico.
ES2498091T3 (es) Procedimiento para producir nanopartículas
CL2009001081A1 (es) Procedimiento para producir un vehiculo en forma de particulas que comprende disolver polibutilcianoacrilado en un disolvente organico para formar una solucion polimerica, anadir una solucion acuosa, mezclar y obtener el vehiculo en forma de particulas; composicion farmaceutica que comprende dicho vehiculo.
BRPI0911317A2 (pt) Formulação desinfetante aquosa compreendendo um composto fenólico, um tensoativo e um solvente
CL2008000156A1 (es) Gel estable hidrofilo en base a un polimero para aplicacion topica porque comprende quitosano disuelto en un solvente; proceso para obtener el gel para uso topico antes mencionado; uso del gel.
UY32761A (es) Preparaciones termoestables y preparaciones insulinicas estables a las vibraciones
BRPI0920786A2 (pt) eletrodo frontal tendo superfície atacada quimicamente para uso em dispositivo fotovoltaico, e processo de produção do mesmo.
BR112014027039A2 (pt) formulação farmacêutica tópica não aquosa; uso de formulação farmacêutica não aquosa; formulação não aquosa; e método
CL2012000401A1 (es) Metodo para hacer una composicion para producir un recubrimiento ultrahidrofobo que comprende combinar un primer solvente y las particulas las cuales no son solubles pero dispersables en primer solvente y combinar con segundo solvente, obtener composicion y recuperacion de la composicion; recubrimiento ultrahidrofobo; y composicion.
AR072685A1 (es) Composicion topica para el tratamiento de queratosis actinica
BRPI0922651A2 (pt) processo para remover um solvente de uma solução fonte.
AR086945A1 (es) Material polimerico para un recipiente aislante
MX2018008224A (es) Metodo para preparar electrodos de baterias.
CL2007003213A1 (es) Sistema surfactante que comprende celulosa microfibrosa a una concentracion de 0,05%-1,0% (p/p), surfactante a 5%-50% (p/p de surfactante activo) y un particulado; y metodo para preparar un sistema surfactante.
AR061990A1 (es) Mejoras relacionadas a composiciones antiparasitarias
BRPI0822235A2 (pt) Processo, sistema e dispositivo de rede para obter prioridade de resseleção de célula.
AR069123A1 (es) Formulacion de surfactante para recuperacion mejorada de petroleo y metodo para prepararla
CL2008000775A1 (es) Un metodo para identificar referencias apropiadas de archivos de ordenes (scripts), en el lado del cliente, desde un servidor de la web.
CL2012001725A1 (es) Procesos para la preparacion de 2-(6-fluoro-1h-indol-3-il)etanamina, a partir de (6-fluoro-1h-indol-3-il)acetonitrilo y un catalizador de metal de transicion en un solvente alcoholico, posteriormente hidrogenar la mezcla con h2.
AR080736A1 (es) Composicion farmaceutica de disolucion rapida, usualmente bucodispersable, y proceso para prepararla
EA201270283A1 (ru) Способ получения соэвапоратов и комплексы, содержащие вориконазол и циклодекстрин
AR076275A1 (es) Uso de una tierra rara para la remocion de antimonio y bismuto
ECSP13013094A (es) Composiciones de limpieza de sal colina
CL2007003859A1 (es) Metodo para eliminar arsenico que comprende contactar la solucion con un agente precipitante de tierra rara para precipitar arsenico y obtener solucion parcialmente liberada de arsenico y agente cargado con arsenico,contactar la solucion separada con una segunda porcion de agente precipitante;y aparato para separar arsenico.
CL2004001426A1 (es) Procedimiento para preparar atorvastatina amorfa que comprende disolver atorvastatina en una solucion que incluye un solvente hidroxilico y evaporar rapidamente dicho solvente desde la solucion; composicion farmaceutica que la contiene, util en el tr